Published in Lancet on February 16, 1991
Deep brain stimulation. Annu Rev Neurosci (2006) 2.65
Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int (2010) 2.60
The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact Funct Neurosurg (2009) 2.24
The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci U S A (2010) 2.21
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Parkinson's disease. J Neurol Neurosurg Psychiatry (1994) 1.84
Network perspectives on the mechanisms of deep brain stimulation. Neurobiol Dis (2009) 1.64
Deep brain stimulation for Parkinson's disease. Neurotherapeutics (2008) 1.53
The nature of tremor circuits in parkinsonian and essential tremor. Brain (2014) 1.51
Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry (1999) 1.49
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry (2002) 1.40
The pros and cons of intraoperative CT scan in evaluation of deep brain stimulation lead implantation: A retrospective study. Surg Neurol Int (2016) 1.37
Deep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in rats. J Neurosci (2008) 1.37
Suppression of epileptiform activity by high frequency sinusoidal fields in rat hippocampal slices. J Physiol (2001) 1.36
Differences among implanted pulse generator waveforms cause variations in the neural response to deep brain stimulation. Clin Neurophysiol (2007) 1.35
Multicentre European study of thalamic stimulation in essential tremor: a six year follow up. J Neurol Neurosurg Psychiatry (2003) 1.23
Shaping plasticity to enhance recovery after injury. Prog Brain Res (2011) 1.20
A feasibility study of optical coherence tomography for guiding deep brain probes. J Neurosci Methods (2006) 1.19
Deep brain stimulation of the globus pallidus internus in the parkinsonian primate: local entrainment and suppression of low-frequency oscillations. J Neurophysiol (2009) 1.18
Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord (2011) 1.18
Tremor varies as a function of the temporal regularity of deep brain stimulation. Neuroreport (2008) 1.17
Mechanisms of deep brain stimulation in movement disorders as revealed by changes in stimulus frequency. Neurotherapeutics (2008) 1.14
Morphological differences in Parkinson's disease with and without rest tremor. J Neurol (2009) 1.12
The history and future of deep brain stimulation. Neurotherapeutics (2008) 1.11
Stimulus features underlying reduced tremor suppression with temporally patterned deep brain stimulation. J Neurophysiol (2011) 1.10
Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease? Front Integr Neurosci (2012) 1.08
Closing the loop of deep brain stimulation. Front Syst Neurosci (2013) 1.07
Desynchronizing electrical and sensory coordinated reset neuromodulation. Front Hum Neurosci (2012) 1.06
Neural prostheses. J Physiol (2001) 1.01
Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor. J Neural Eng (2012) 1.01
Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry (1993) 1.00
Minimally invasive surgery. Neurosurgery. BMJ (1994) 1.00
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2012) 0.99
Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. J Neurol (1999) 0.98
Deep brain stimulation: technology at the cutting edge. J Clin Neurol (2010) 0.97
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's disease. Exp Brain Res (2006) 0.97
Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? Neurotherapeutics (2016) 0.96
The treatment of movement disorders by deep brain stimulation. Neurotherapeutics (2008) 0.96
Tremor disorders. Diagnosis and management. West J Med (1995) 0.96
A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies. Front Neurosci (2014) 0.96
Phase dependent modulation of tremor amplitude in essential tremor through thalamic stimulation. Brain (2013) 0.95
Motor thalamus integration of cortical, cerebellar and basal ganglia information: implications for normal and parkinsonian conditions. Front Comput Neurosci (2013) 0.95
Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems. Neurosurg Rev (2005) 0.95
Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci (2011) 0.94
The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry (2005) 0.94
Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state. Front Neuroanat (2015) 0.93
Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders. Front Biosci (2008) 0.92
Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry (1999) 0.92
Engineering the next generation of clinical deep brain stimulation technology. Brain Stimul (2014) 0.92
Potential utility of optogenetics in the study of depression. Biol Psychiatry (2012) 0.91
Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease. J Neurol (2007) 0.91
Distinguishing the central drive to tremor in Parkinson's disease and essential tremor. J Neurosci (2015) 0.91
Modified pulse shapes for effective neural stimulation. Front Neuroeng (2011) 0.91
The autonomic effects of deep brain stimulation--a therapeutic opportunity. Nat Rev Neurol (2012) 0.91
Deep brain stimulation entrains local neuronal firing in human globus pallidus internus. J Neurophysiol (2012) 0.91
Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases. Neurol Sci (2012) 0.90
Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome. Clin Neurol Neurosurg (2008) 0.90
Deep brain stimulation imposes complex informational lesions. PLoS One (2013) 0.89
Deep brain stimulation for movement disorders. Neurotherapeutics (2014) 0.89
Recording evoked potentials during deep brain stimulation: development and validation of instrumentation to suppress the stimulus artefact. J Neural Eng (2012) 0.89
Functional neurosurgery for Parkinson's disease. Has come a long way, though much remains experimental. BMJ (1998) 0.88
Optimizing a rodent model of Parkinson's disease for exploring the effects and mechanisms of deep brain stimulation. Parkinsons Dis (2011) 0.88
MRI directed bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 0.88
Deep brain stimulation: are astrocytes a key driver behind the scene? CNS Neurosci Ther (2014) 0.86
STDP in Oscillatory Recurrent Networks: Theoretical Conditions for Desynchronization and Applications to Deep Brain Stimulation. Front Comput Neurosci (2010) 0.86
Frequency-dependent functional neuromodulatory effects on the motor network by ventral lateral thalamic deep brain stimulation in swine. Neuroimage (2014) 0.86
Thalamic stimulation for severe action tremor after lesion of the superior cerebellar peduncle. J Neurol Neurosurg Psychiatry (1995) 0.86
Improved focalization of electrical microstimulation using microelectrode arrays: a modeling study. PLoS One (2009) 0.86
Pallidal stimulation: effect of pattern and rate on bradykinesia in the non-human primate model of Parkinson's disease. Exp Neurol (2011) 0.85
Industrial perspective on deep brain stimulation: history, current state, and future developments. Front Integr Neurosci (2011) 0.85
Impact of nonlinear delayed feedback on synchronized oscillators. J Biol Phys (2008) 0.85
Impact of thalamic deep brain stimulation on disability and health-related quality of life in patients with essential tremor. J Neurol Neurosurg Psychiatry (2002) 0.85
Axonal and synaptic failure suppress the transfer of firing rate oscillations, synchrony and information during high frequency deep brain stimulation. Neurobiol Dis (2013) 0.85
Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders. Neuropsychiatr Dis Treat (2015) 0.85
Deep brain stimulation. Interv Neurol (2013) 0.84
Disrupting neuronal transmission: mechanism of DBS? Front Syst Neurosci (2014) 0.84
Novel applications of deep brain stimulation. Surg Neurol Int (2012) 0.83
Deep brain stimulation as a tool for improving cognitive functioning in Alzheimer's dementia: a systematic review. Front Psychiatry (2013) 0.83
Isolated thalamic agraphia with impaired grapheme formation and micrographia. J Neurol (2011) 0.83
Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci (2006) 0.82
Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients. J Neural Transm (Vienna) (2011) 0.82
Somatic treatments for mood disorders. Neuropsychopharmacology (2011) 0.82
Parkinson's disease. Subcell Biochem (2012) 0.82
Neural circuit modulation during deep brain stimulation at the subthalamic nucleus for Parkinson's disease: what have we learned from neuroimaging studies? Brain Connect (2013) 0.82
Movement disorders and neuromodulation. Neurol Res Int (2012) 0.82
Fornix deep brain stimulation circuit effect is dependent on major excitatory transmission via the nucleus accumbens. Neuroimage (2016) 0.82
Surgery for Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 0.82
Stimulating at the right time: phase-specific deep brain stimulation. Brain (2016) 0.81
The nucleus accumbens: a target for deep brain stimulation in resistant major depressive disorder. J Mol Psychiatry (2013) 0.81
Feedback suppression of neural synchrony in two interacting populations by vanishing stimulation. J Biol Phys (2008) 0.81
Tractography-Based Ventral Intermediate Nucleus Targeting: Novel Methodology and Intraoperative Validation. Mov Disord (2016) 0.81
Functional connectivity targeting for deep brain stimulation in essential tremor. AJNR Am J Neuroradiol (2011) 0.80
Consensus Paper: Towards a Systems-Level View of Cerebellar Function: the Interplay Between Cerebellum, Basal Ganglia, and Cortex. Cerebellum (2017) 0.80
Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity. Short communication. J Neural Transm (Vienna) (1997) 0.80
Desynchronization boost by non-uniform coordinated reset stimulation in ensembles of pulse-coupled neurons. Front Comput Neurosci (2013) 0.80
Multi-frequency activation of neuronal networks by coordinated reset stimulation. Interface Focus (2010) 0.80
Neural origin of evoked potentials during thalamic deep brain stimulation. J Neurophysiol (2013) 0.80
Kilohertz Frequency Deep Brain Stimulation Is Ineffective at Regularizing the Firing of Model Thalamic Neurons. Front Comput Neurosci (2016) 0.79
Anesthetic challenges for deep brain stimulation: a systematic approach. N Am J Med Sci (2014) 0.79
Postmortem diffusion MRI of the human brainstem and thalamus for deep brain stimulator electrode localization. Hum Brain Mapp (2015) 0.79
Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med (1989) 6.79
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Chemical studies on tobacco smoke LIX. Analysis of volatile nitrosamines in tobacco smoke and polluted indoor environments. IARC Sci Publ (1978) 4.50
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Health risks associated with cigar smoking. JAMA (2000) 3.36
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Antimicrobial peptides in insects; structure and function. Dev Comp Immunol (1999) 3.09
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci U S A (1983) 2.84
Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen. J Exp Med (1983) 2.76
Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem Biol (1998) 2.64
Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg (2002) 2.62
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Insect immunity: developmental and inducible activity of the Drosophila diptericin promoter. EMBO J (1992) 2.46
Insect immunity. Characterization of a Drosophila cDNA encoding a novel member of the diptericin family of immune peptides. J Biol Chem (1990) 2.40
Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis (1988) 2.37
Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol (2001) 2.32
A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med (1993) 2.28
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med (1999) 2.11
The reemergence of smokeless tobacco. N Engl J Med (1986) 2.00
Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res (1988) 1.96
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology (2002) 1.89
Characterization and transcriptional profiles of a Drosophila gene encoding an insect defensin. A study in insect immunity. Eur J Biochem (1994) 1.85
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer (1996) 1.78
Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. Carcinogenesis (1995) 1.76
Elimination from the body of tobacco products by smokers and passive smokers. JAMA (1986) 1.76
Reported cigarette smoke values: a closer look. Am J Public Health (1983) 1.75
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol (1978) 1.70
Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66
Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep (1995) 1.66
Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus. N Engl J Med (1985) 1.62
Is it clinically possible to distinguish nonhemorrhagic infarct from hemorrhagic stroke? Stroke (1995) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res (1985) 1.58
Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop (2001) 1.57
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56
The less harmful cigarette. Prev Med (1980) 1.53
Nicotine regulates smoking patterns. Prev Med (1997) 1.52
Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev (1997) 1.52
Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol (1997) 1.48
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord (1998) 1.47
The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv (1989) 1.46
Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res (1986) 1.45
Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43
Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer (1997) 1.42
Mixed infections with Plasmodium falciparum and P malariae and fever in malaria. Lancet (1994) 1.42
Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42
Smoking and lung cancer: scientific challenges and opportunities. Cancer Res (1994) 1.42
N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev (1998) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41
[French language training course: malaria workshop organized by Institut Pasteur de Madagascar]. Med Trop (Mars) (2007) 1.40
[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. Rev Neurol (Paris) (2000) 1.39
Tobacco and health: a societal challenge. N Engl J Med (1979) 1.38
Plasmodium chabaudi: a rodent malaria model for in-vivo and in-vitro cytoadherence of malaria parasites in the absence of knobs. Parasite Immunol (1987) 1.38
Practice parameters for the management of colonic cancer I: surgical issues. Recommendations of the Colorectal Surgical Society of Australia. Aust N Z J Surg (1999) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst (1997) 1.34
Basal ganglia involvement in rotational seizures. Epileptic Disord (1999) 1.33
Low-field MRI of laser polarized noble gas. Phys Rev Lett (1998) 1.33
Analysis for nicotine and cotinine in hair to determine cigarette smoker status. Clin Chem (1985) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28
Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27
Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis (1999) 1.27
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Formation and analysis of carbon monoxide in cigarette mainstream and sidestream smoke. Prev Med (1979) 1.27